ProFibrix expands management team
This article was originally published in Scrip
Executive Summary
ProFibrix, a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, has appointed Dr Jan Ohrstrom chief operating officer and to its executive management team. He will be based in Seattle, US, where ProFibrix has established a wholly owned subsidiary – ProFibrix Inc. Dr Ohrstrom was previously part of the senior management team that took ZymoGenetics public.